摘要
那格列奈是一种新型口服降血糖药 ,它通过刺激胰岛素释放而降低血糖 ,与磺酰脲类药物相比 ,本品降血糖作用起效快 ,维持时间短 ,可有效降低餐后血糖水平。本文综述了那格列奈的药理学、毒理学。
Nateglinide is a novel oral hypoglycemic agent that lowers blood glucose by stimulating insulin release, it exhibits a more rapid onset and shorter duration of hypoglycemic action than the sulphonylureas. It can effectively suppress the postprandial blood excursion. This paper reviews the progress in the pharmacology, toxicology, pharmacokinetics and clinical studies of nateglinide.
出处
《中国新药与临床杂志》
CAS
CSCD
北大核心
2002年第1期43-45,共3页
Chinese Journal of New Drugs and Clinical Remedies
关键词
那格列奈
糖尿病
降血糖药
药理学
毒理学
药动学
治疗
nateglinide
diabetes mellitus non insulin dependent
hypoglycemic agents
pharmacology
toxicology
pharmacokinetics
